Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Five Stocks Surging Today?

Page 1 of 2

All three indexes are in either in the green or relatively flat on Tuesday and leading the gainers are five stocks: Argos Therapeutics Inc (NASDAQ:ARGS), American Midstream Partners LP (NYSE:AMID), Oneok Partners LP (NYSE:OKS), Plains GP Holdings LP (NYSE:PAGP), and Peabody Energy Corporation (NYSE:BTU), each of which are rallying for different reasons. Let’s take a closer look at why investors are buying.

Given that Insider Monkey has done a lot of research into what the smart money likes and doesn’t like, let’s also analyze relevant hedge fund sentiment toward the stocks. But why do we track hedge fund activity? From one point of view we can argue that hedge funds are consistently underperforming when it comes to net returns over the last three years, when compared to the S&P 500. But that doesn’t mean that we should completely neglect their activity. There are various reasons behind the low hedge fund returns. Our research indicated that hedge funds’ long positions actually beat the market. In our back-tests covering the 1999-2012 period hedge funds’ top small-cap stocks edged the S&P 500 index by double digits annually. The 15 most popular small-cap stock picks among hedge funds also bested passive index funds by around 53 percentage points over the 36 month period beginning from September 2012 (see the details here).

Argos Therapeutics Inc (NASDAQ:ARGS) shares have rocketed by 26% higher in afternoon trading on technical buying. Because shares have been badly beaten up year-to-date, some short investors are taking some profits as the tax year and fourth quarter comes to a close. Throw in the company’s relative illiquidity (the stock has an average 3 month daily volume of around 58,000 shares) and today’s rally makes a lot more sense. Of the around 730 elite funds we track, one fund owned around 0.7% of Argos Therapeutics Inc (NASDAQ:ARGS)’s float on September 30.

American Midstream Partners LP (NYSE:AMID) surged for the second day in a row after ArcLight Capital Partners announced that it might buy up to $75 million of American Midstream Partners’ shares beginning today. ArcLight controls the general partner of American Midstream Partners LP and is contemplating buying shares because the fund feels America Midstream Partners’ stock is undervalued in relation to its assets. Seeing as American Midstream Partners LP (NYSE:AMID)’s market cap is only $190 million, a purchase of $75 million would definitely make a big difference in the stock (although there is no guarantee that ArcLight will buy anywhere close to $75 million). Shares of American Midstream Partners are up 25% so far today.

Follow American Midstream Partners Lp (NYSE:AMID)
Trade (NYSE:AMID) Now!

On the next page, we examine Oneok Partners LP, Plains GP Holdings LP, and Peabody Energy Corporation.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!